.406 Ventures

.406 Ventures, LLC is a Boston-based venture capital firm founded in 2005 that specializes in early-stage investments, particularly in the information technology sector. The firm focuses on innovative companies in areas such as IT security and infrastructure, digital health, cloud technology, financial technology, and next-generation software. .406 Ventures typically invests between $2 million and $5 million initially, with total investments ranging from $6 million to $10 million per company. The firm seeks to be the lead institutional investor and often acquires significant stakes, ranging from 20 percent to 80 percent. It aims to provide board representation and actively supports its portfolio companies with its extensive industry experience and networks. Additionally, .406 Ventures allocates capital for opportunistic investments in more mature companies where technological shifts present growth opportunities. The firm primarily targets companies located in the Northeast and Southeast regions of the United States.

Lawrence P. Begley

Co-Founder

Graham Brooks

Partner

Maria Cirino

Co-Founder & Managing Partner

Payal Agrawal Divakaran

Partner

Liam Donohue

Co-Founder & Managing Partner

Greg Dracon

Partner

Eliza Loring

Associate

Rob McCall

Associate

So-June Min

Managing Director of Operations

Kathryn Taylor Reddy

Principal

Rebecca Redfield

Associate

Kara Sweeney

Associate

Kevin Wang

Principal

Past deals in Tennessee

Wayspring

Series D in 2021
Wayspring, formerly known as Axial Healthcare, Inc., is a Nashville-based company that develops a cloud-based clinical decision support platform aimed at managing the cost and quality of patient care, particularly in the realm of substance use disorders (SUD). The platform connects patients, healthcare providers, and health plans, offering individualized solutions that span the entire spectrum of substance use, from risk assessment to recovery. It includes features such as predictive analytics and a decision-support system that provides insights into pain management and opioid-related risks. The technology facilitates data-driven decision-making at the point of care, equipping healthcare professionals with essential tools and information to identify at-risk patients and ensure continuity of care. Through its interactive platform, Wayspring aims to improve healthcare outcomes by mending fragmented care systems and supporting patients on their recovery journey.

Wayspring

Series C in 2020
Wayspring, formerly known as Axial Healthcare, Inc., is a Nashville-based company that develops a cloud-based clinical decision support platform aimed at managing the cost and quality of patient care, particularly in the realm of substance use disorders (SUD). The platform connects patients, healthcare providers, and health plans, offering individualized solutions that span the entire spectrum of substance use, from risk assessment to recovery. It includes features such as predictive analytics and a decision-support system that provides insights into pain management and opioid-related risks. The technology facilitates data-driven decision-making at the point of care, equipping healthcare professionals with essential tools and information to identify at-risk patients and ensure continuity of care. Through its interactive platform, Wayspring aims to improve healthcare outcomes by mending fragmented care systems and supporting patients on their recovery journey.

Wayspring

Series B in 2016
Wayspring, formerly known as Axial Healthcare, Inc., is a Nashville-based company that develops a cloud-based clinical decision support platform aimed at managing the cost and quality of patient care, particularly in the realm of substance use disorders (SUD). The platform connects patients, healthcare providers, and health plans, offering individualized solutions that span the entire spectrum of substance use, from risk assessment to recovery. It includes features such as predictive analytics and a decision-support system that provides insights into pain management and opioid-related risks. The technology facilitates data-driven decision-making at the point of care, equipping healthcare professionals with essential tools and information to identify at-risk patients and ensure continuity of care. Through its interactive platform, Wayspring aims to improve healthcare outcomes by mending fragmented care systems and supporting patients on their recovery journey.

Wayspring

Series A in 2015
Wayspring, formerly known as Axial Healthcare, Inc., is a Nashville-based company that develops a cloud-based clinical decision support platform aimed at managing the cost and quality of patient care, particularly in the realm of substance use disorders (SUD). The platform connects patients, healthcare providers, and health plans, offering individualized solutions that span the entire spectrum of substance use, from risk assessment to recovery. It includes features such as predictive analytics and a decision-support system that provides insights into pain management and opioid-related risks. The technology facilitates data-driven decision-making at the point of care, equipping healthcare professionals with essential tools and information to identify at-risk patients and ensure continuity of care. Through its interactive platform, Wayspring aims to improve healthcare outcomes by mending fragmented care systems and supporting patients on their recovery journey.